The globalization of cancer clinical trials is associated with a widening racial disparity in enrollment, according to a study published online March 8 in Cancer. Serena Tharakan, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues analyzed race and accrual location data for all U.S. Food and Drug Administration-approved...